North America will continue to be the Leading Market for Neuropathic Pain over the Forecast Period (2016–2024)
According to a recent study conducted by RRI, the global market for neuropathic pain is expected to reflect a CAGR of over 5% during the forecast period (2016–2024). In 2015, the market was valued at over US$ 5 Billion and is estimated to stand at US$ 8.3 Billion by 2024 end.
Factors such as increasing prevalence of chronic disorders including cancer ... Read more
North America will continue to be the Leading Market for Neuropathic Pain over the Forecast Period (2016–2024)
According to a recent study conducted by RRI, the global market for neuropathic pain is expected to reflect a CAGR of over 5% during the forecast period (2016–2024). In 2015, the market was valued at over US$ 5 Billion and is estimated to stand at US$ 8.3 Billion by 2024 end.
Factors such as increasing prevalence of chronic disorders including cancer ... Read more
North America will continue to be the Leading Market for Neuropathic Pain over the Forecast Period (2018–2026)
According to a recent study conducted by TMR, the global market for neuropathic painis expected to reflect a CAGR of over XX% during the forecast period (2018–2026). In 2015, the market was valued at over US$ XX Billion and is estimated to stand at US$ XX Billion by 2026 end ... Read more
Neuropathic pain refers to a condition of chronic pain that is caused by a primary lesion such as trauma, infection, or other dysfunction in the nervous system. Prominent syndromes of neuropathic pain include root avulsions, postherpetic neuralgia, painful traumatic mononeuropathy, painful polyneuropathy, postsurgical pain syndromes, central pain syndromes, and complex regional pain syndrome. Some of the usual medications ... Read more